White label ELPA - ClinicalTrials.eu

Study comparing 177Lu-edotreotide versus everolimus in patients with inoperable progressive neuroendocrine tumors of gastroenteric or pancreatic origin

Not recruiting

3 1 1 1
Investigated diseases:
- Gastroenteropancreatic neuroendocrine tumour disease
Investigated drugs:
+3
Study on the Long-term Effects of Givinostat for Patients with JAK2V617F Positive Chronic Myeloproliferative Neoplasms

Not recruiting

2 1 1
Investigated drugs:
- Givinostat
Study on Preventing Acute Kidney Injury in Cardiac Surgery Patients Using Dapagliflozin

Not recruiting

3 1 1 1
Investigated drugs:
- Dapagliflozin
Study on the Long-Term Safety of Bepranemab for Adults with Progressive Supranuclear Palsy

Not recruiting

1 1 1
Investigated diseases:
- Progressive supranuclear palsy
Investigated drugs:
- Bepranemab
Study of Ipatasertib with Trastuzumab and Pertuzumab for Patients with Advanced HER2-Positive Breast Cancer and PIK3CA Mutation

Not recruiting

1 1 1 1
Investigated diseases:
- HER2 positive breast cancer
Investigated drugs:
Study on R3R01 for Patients with Alport Syndrome and Primary Steroid-Resistant Focal Segmental Glomerulosclerosis

Not recruiting

2 1 1
Investigated diseases:
- Alport’s syndrome
- Focal segmental glomerulosclerosis
Investigated drugs:
- R3R01
Study on Radiotherapy with Nimotuzumab and Vinorelbine for Newly Diagnosed Childhood and Adolescent Diffuse Intrinsic Pontine Glioma (DIPG) Patients

Not recruiting

2 1 1 1
Investigated diseases:
- Brain stem glioma
Investigated drugs:
- Nimotuzumab
- Vinorelbine Tartrate
Study Comparing Sacituzumab Govitecan and Docetaxel for Patients with Advanced or Metastatic Non-Small Cell Lung Cancer After Previous Treatments

Not recruiting

3 1 1 1
Investigated diseases:
- Non-small cell lung cancer
Investigated drugs:
- Sacituzumab Govitecan
- Docetaxel
+4
Study on Long-term Safety and Effectiveness of NMRA-335140 for Patients with Major Depressive Disorder

Not recruiting

3 1 1
Investigated drugs:
- 1-[6-Ethyl-8-Fluoro-4-Methyl-3-(3-Methyl-1,2,4-Oxadiazol-5-Yl)Quinolin-2-Yl]-N-(Oxan-4-Yl)Piperidin-4-Amine
+1
Study on Long-term Safety of VX-121, Tezacaftor, and Deutivacaftor in Patients with Cystic Fibrosis

Not recruiting

3 1 1 1
Investigated drugs:
- Tezacaftor
- Vanzacaftor
+10

Full Name *

e-Mail *

Country Prefix *

Phone Number *

Nationality *

Gender *

Check all consents

Check all consents

I accept the Terms and Conditions and Privacy Policy *

*I accept the Terms and Conditions and Privacy Policy

I consent to receiving commercial information from the Service Operator *

*I consent to receiving commercial information from the Service Operator

I consent to the use of telecommunications terminal equipment and automated calling systems by the Service Operator for marketing communication purposes *

*I consent to the use of telecommunications terminal equipment and automated calling systems by the Service Operator for marketing communication purposes

We use cookies